Protein misfolding in neurodegenerative diseases: implications and strategies. - Test2 - elhamkhani - TriplyDB

Protein misfolding in neurodegenerative diseases: implications and strategies.

Protein misfolding in neurodegenerative diseases: implications and strategies.

http://www.wikidata.org/entity/Q37697832

about

Fine-tuning PERK signaling for neuroprotection.The Emerging Role of GLP-1 Receptors in DNA Repair: Implications in Neurological Disorders.Anti-inflammatory effects of hypoxia-preconditioned human periodontal ligament cell secretome in an experimental model of multiple sclerosis: a key role of IL-37.Regioselective and enantiospecific synthesis of the HSP co-inducer arimoclomol from chiral glycidyl derivatives.Comparison of spinocerebellar ataxia type 3 mouse models identifies early gain-of-function, cell-autonomous transcriptional changes in oligodendrocytes.Adult-onset brain tumors and neurodegeneration: Are polyphenols protective?HDAC6 Inhibition Promotes Transcription Factor EB Activation and Is Protective in Experimental Kidney Disease.Pharmacoperones as Novel Therapeutics for Diverse Protein Conformational Diseases.Solvation-Guided Design of Fluorescent Probes for Discrimination of Amyloids.Neuroprotection Targeting Protein Misfolding on Chronic Cerebral Hypoperfusion in the Context of Metabolic Syndrome.Inhibition of Protein Aggregation by Several Antioxidants.Theranostic applications of nanoparticles in neurodegenerative disorders Different Structural Conformers of Monomeric α-Synuclein Identified after Lyophilizing and Freezing ALS Yeast Models—Past Success Stories and New Opportunities Synaptic dysfunction in neurodegenerative and neurodevelopmental diseases: an overview of induced pluripotent stem-cell-based disease models NLRP3 expression in mesencephalic neurons and characterization of a rare NLRP3 polymorphism associated with decreased risk of Parkinson’s disease

P2860

Q39393398-AFD100CD-0AEA-4757-9C98-D2063B91FFFF Q41661210-00439078-4F9C-4B99-B3AC-2E9EC56C5C43 Q47131819-32EC9D53-B2F5-46EF-82AD-61F1817C6621 Q47438160-46FB492F-A38A-46D5-ADAA-8EE4D80343F4 Q47882715-28A5C533-FCC6-46E3-A899-F251C79ABCB4 Q48105691-60D52A41-2382-4F9F-80BF-D5934EB6E70E Q49620168-8FA8654D-0F7F-49D9-AF81-15C0762118B7 Q50014672-EB5D1AB5-3165-421E-8783-FE0206CDEC53 Q55053546-BB3DC79F-7641-409F-834E-E3C125062EC0 Q55109555-C3BF182A-4CCD-4FAF-902B-B4087EAD3945 Q55276020-304CFC31-4816-4B98-ABE0-24E7B59FA6F6 Q57071940-FFD53E48-951D-4532-AB3F-81BDD99A6B40 Q57948233-C376DCD1-6709-42D3-92B5-68C761C4EB17 Q58698109-947E71C5-FDF6-4B1F-A0EC-DF754EBB50D1 Q58762401-90E94DA9-4BAA-4F6A-A7D1-EBE87D9D8495 Q58778263-704484F8-DBB6-4FFF-B587-298F53AA9E38

P2860

Protein misfolding in neurodegenerative diseases: implications and strategies.

http://www.wikidata.org/entity/Q37697832

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 13 March 2017

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Protein misfolding in neurodegenerative diseases: implications and strategies.

@en

Protein misfolding in neurodegenerative diseases: implications and strategies.

@nl

type

label

Protein misfolding in neurodegenerative diseases: implications and strategies.

@en

Protein misfolding in neurodegenerative diseases: implications and strategies.

@nl

prefLabel

Protein misfolding in neurodegenerative diseases: implications and strategies.

@en

Protein misfolding in neurodegenerative diseases: implications and strategies.

@nl

P1433

Q37697832-9CD50C99-B7ED-4E9A-9097-3EC8EACB8304

P1476

Q37697832-25098CB2-25BF-4E38-BABB-8D681E4C9FE8

P2093

Q37697832-11F43EB5-5F78-4964-864C-D425D00D90A1

Q37697832-21986B88-DB38-43D4-8840-890EF3158DB4

Q37697832-532368BC-C17B-4681-BD46-C67AEE9F4BA5

Q37697832-57C6C3AC-298A-4206-9574-930A264BA409

Q37697832-5FF25807-A6FA-49F0-9928-CA27252C7227

Q37697832-8A981DF2-D589-45D8-8787-72120EB0593E

Q37697832-CFD7D759-CD5B-46B4-B12D-3D276AB524CD

Q37697832-EB920C7F-C90B-4D11-8D3F-0FB90AE66F0D

Q37697832-F7DE00E5-E316-4901-B095-A6CF5108065B

Q37697832-FE539047-046B-4EBF-8417-42C6214D25BD

P2860

Q37697832-016C0E74-758B-4CDF-9B8C-41891E055645

Q37697832-0215A8BA-D3DE-4A24-9DB2-103963476CC6

Q37697832-022E1AD4-8760-447F-896D-27763F0873EF

Q37697832-0437B2EC-8EE0-4322-B1EF-CB8B245A5AB5

Q37697832-04B4E74F-D0FA-41F3-AF7B-6BAB35C28D06

Q37697832-04B74B61-D9D6-4F0E-B5B9-B268CD4B72B5

Q37697832-064F49FB-0712-4991-BE08-9F3316DAE30E

Q37697832-06A7FCAB-AC3E-4B19-BB33-26694D088E23

Q37697832-07FCA64F-2451-4903-9DC6-551B3A6051B6

Q37697832-0A9E65C0-248B-4BA4-BB98-2E55E1EB4BF7

P2888

Q37697832-DA9E585A-98BD-4658-B98B-539F1C939F91

P304

Q37697832-5D628413-1595-4A7D-8236-7BDA3C022E50

P31

Q37697832-3291F821-F286-4279-8C14-7127644E5B28

P356

Q37697832-FA27011C-9422-482C-97EC-759231244235

P478

Q37697832-9DC6EF05-850C-4F10-91EC-03D27BEB233F

P50

Q37697832-52673A88-8F0A-4F88-B489-E432489F9C57

P577

Q37697832-98751AA6-DABE-4DBE-A95F-07469EC312E5

P6179

Q37697832-A1F59071-B409-469D-8465-5468B5AB21FC

P698

Q37697832-86C9DF67-B0B4-4CCD-ADD2-78A11D4530AC

P921

Q37697832-BC22680F-3F40-4255-B5CC-D47D585BE848

P932

Q37697832-3CFB3537-2907-41B7-A611-56DAFCCEE149

P356

S40035-017-0077-5

P1433

Translational Neurodegeneration

P1476

Protein misfolding in neurodegenerative diseases: implications and strategies.

@en

P2093

Alexander McCampbell

http://www.w3.org/2001/XMLSchema#string

Anjli Venkateswaran

http://www.w3.org/2001/XMLSchema#string

Antti Nurmi

http://www.w3.org/2001/XMLSchema#string

Gabrielle Leblanc

http://www.w3.org/2001/XMLSchema#string

Hyunsun Park

http://www.w3.org/2001/XMLSchema#string

John Dunlop

http://www.w3.org/2001/XMLSchema#string

Marc Baumann

http://www.w3.org/2001/XMLSchema#string

Patrick Sweeney

http://www.w3.org/2001/XMLSchema#string

Robert Hodgson

http://www.w3.org/2001/XMLSchema#string

Ron Kopito

http://www.w3.org/2001/XMLSchema#string

P2860

Interface between tauopathies and synucleinopathies: A tale of two proteins

ApoE-directed therapeutics rapidly clear β-amyloid and reverse deficits in AD mouse models

Aging as an event of proteostasis collapse

Exome sequencing reveals VCP mutations as a cause of familial ALS

Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory

Misfolded proteins partition between two distinct quality control compartments

Engineering and Evolution of Molecular Chaperones and Protein Disaggregases with Enhanced Activity

Neuronal response in Alzheimer's and Parkinson's disease: the effect of toxic proteins on intracellular pathways

Challenges and opportunities for non-antibody scaffold drugs

Chaperones in Neurodegeneration

P2888

s40035-017-0077-5

P304

6

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S40035-017-0077-5

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-03-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1084252759

http://www.w3.org/2001/XMLSchema#string

P698

28293421

http://www.w3.org/2001/XMLSchema#string

P921

neurodegeneration

P932

5348787

http://www.w3.org/2001/XMLSchema#string